Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD.